The effect of the steroid-sparing response to low-dose methotrexate on bone metabolism in glucocorticoid-dependent asthmatics.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000032:analysis / Q000378:metabolism; D000596:Amino Acids / Q000737:chemistry / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D015415:Biomarkers; D001842:Bone and Bones / Q000201:enzymology / Q000378:metabolism*; D002986:Clinical Trials as Topic; D024042:Collagen Type I / Q000737:chemistry / Q000378:metabolism; D003404:Creatinine / Q000652:urine; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D015675:Osteocalcin / Q000032:analysis / Q000378:metabolism; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012189:Retrospective Studies
D000596:Amino Acids; D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D024042:Collagen Type I; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D015675:Osteocalcin; C036020:deoxypyridinoline; D011239:Prednisolone; D003404:Creatinine; D000469:Alkaline Phosphatase; D008727:Methotrexate